Reviews
Now Reading
ScreenPoint Medical
0
Review

ScreenPoint Medical

Overview
Synopsis

ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis with solutions such as Transpara Decision Support, Transpara Score, and Transpara CAD.

Category

AI-based Medical Imaging – Breast Imaging

Features

• Deep learning
• Image analysis technology
• Digital breast tomosynthesis
• Transpara Decision Support
• Transpara Score
• Transpara CAD
• Breast cancer detection
• mammograms reading

License

Proprietary

Price

Contact for Pricing

Pricing

Subscription

Free Trial

Available

Users Size

Small (<50 employees), Medium (50 to 1000 employees), Enterprise (>1001 employees)

Company

ScreenPoint Medical

What is best?

• Deep learning
• Image analysis technology
• Digital breast tomosynthesis
• Transpara Decision Support
• Transpara Score
• Transpara CAD
• Breast cancer detection

What are the benefits?

• Interactive decision support
• Eliminates false positives
• Concurrent information provision
• Automatic mammogram reading
• Intelligent context exploitation

PAT Rating™
Editor Rating
Aggregated User Rating
Rate Here
Ease of use
7.6
6.1
Features & Functionality
7.6
8.3
Advanced Features
7.6
7.9
Integration
7.6
Performance
7.6
Customer Support
7.6
Implementation
Renew & Recommend
Bottom Line

ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis with solutions such as Transpara Decision Support, Transpara Score, and Transpara CAD.

7.6
Editor Rating
7.4
Aggregated User Rating
3 ratings
You have rated this

ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis with solutions such as Transpara Decision Support, Transpara Score, and Transpara CAD. It exploits the latest methods in the rapidly evolving field of machine learning, combining these with very large well curated digital image databases and a thorough understanding of the physics of mammogram image formation and the practicalities of the clinical deployment of mammographic image analysis.

Transpara decision Support is a novel concept for computer aided detection of breast cancer developed by the founders of ScreenPoint. It recognizes the fact that radiologists need decision support and not just marks to support search for abnormalities, for both soft tissue lesions and calcifications. Readers can probe suspicious image regions for decision support. Transpara™ Score categorizes every mammogram on a 10-point scale based on image analysis and deep learning algorithms. If no potential abnormalities are found a low score is assigned.

When there are suspicious findings a higher score is assigned. Transpara™ CAD provides calcification CAD marks that can be viewed on both the mammography reading station and the Transpara™ Tablet Viewer. Additionally, very few soft-tissue lesion marks are shown with extremely low false positive rates. The Transpara DBT application provides information to significantly improve reading workflow for DBT on breast reading workstations. With Transpara, the reader can automatically jump to a relevant DBT slice in both the CC and MLO 3D data, by simply clicking on a suspicious region in a synthetic mammogram. Transpara DBT marks the lesion in the relevant slices and provides quantitative decision support for individual soft tissue lesions and calcifications.

Filter reviews
User Ratings





User Company size



User role





User industry





Ease of use
Features & Functionality
Advanced Features
Integration
Performance
Customer Support
Implementation
Renew & Recommend

What's your reaction?
Love It
0%
Very Good
0%
INTERESTED
0%
COOL
0%
NOT BAD
0%
WHAT !
0%
HATE IT
0%